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ABSTRACT
Enterobacter cloacae (n = 110) isolates from a
district hospital in Taiwan were screened for
extended-spectrum b-lactamases (ESBLs). In to-
tal, 17 ESBL-producers were identified, based on
the combination-disk synergy test using cefotax-
ime and ceftazidime ± clavulanic acid. Investiga-
tion of ESBL genes in 33 ceftazidime-resistant
isolates revealed the SHV-12 gene in the same 17
ESBL-producers. In addition, one isolate also
carried the CTX-M-3 gene, and two isolates also
carried the CTX-M-9 gene. No major epidemic
clone of ESBL-producers was identified by
pulsed-field gel electrophoresis. Routine screen-
ing for the ESBL phenotype, focusing on ceftaz-
idime-resistant E. cloacae, should be undertaken
in this area.
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Enterobacter cloacae is a major nosocomial patho-
gen, with susceptibility rates to cefotaxime or
ceftazidime in Taiwan of 35–60% [1,2]. In con-
trast, the fourth-generation cephalosporin cefepi-
me has remained highly active against E. cloacae
[2]. These resistance profiles suggest that AmpC
derepression or hyper-production is conferring
resistance to the third-generation cephalosporins
[3]. However, production of extended-spectrum
b-lactamases (ESBLs) by E. cloacae isolates in
Taiwan [4,5] and worldwide [6–8] has been
reported, raising the possibility of therapeutic
failure with isolates apparently susceptible to
cefepime [9]. Recently, SHV-12 carriage has been
identified among E. cloacae isolates from two large
(>1200 beds) hospitals in northern Taiwan [4,5].
Therefore, the aim of the present study was to
identify and characterise any ESBLs present
among the E. cloacae isolates from a district
hospital (c.600 beds) in a rural area of central
Taiwan.
During 2001, 110 non-repetitive isolates of E.
cloacae were collected from specimens of wound
pus (35%), urine (25%), sputum (20%), blood
(10%), catheter tips (6%) and drained pus (4%).
MICs for all isolates were determined by the agar
microdilution method, with the ESBL phenotype
being indicated by a reduction of ‡ 3 log2 dilu-
tions in the MICs of either ceftazidime (CAZ) or
cefotaxime (CTX) in the presence of clavulanic
acid 4 mg ⁄L [10]. Combination-disk synergy tests
using CTX (30 lg) or CAZ (30 lg) ± clavulanic
acid (CLA; 10 lg) were compared as a test for the
presence of ESBLs, which was confirmed by a
‡ 5-mm increase in zone diameter size for
CTX + CLA or CAZ + CLA vs. the zone diameter
size when CTX or CAZ was tested alone [11]. The
double-disk synergy test, using cefepime and
amoxycillin-clavulanic acid disks (placed 20 mm
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apart, centre to centre), was performed as des-
cribed previously [8].
Crude protein extracts containing b-lactamases
were prepared by ultrasonication, followed by
determination of isoelectric points (pIs) by ana-
lytical isoelectric focusing (IEF) on an ampholin
polyacrylamide gel (pH 3.5–9.5) [12]. Standards of
known pI included TEM-1 (pI 5.4), TEM-4 (pI 5.9),
SHV-3 (pI 7.0), SHV-1 (pI 7.6), SHV-4 (pI 7.8) and
SHV-5 (pI 8.2). Conjugation experiments were
performed with Escherichia coli J53 (Azir) as the
recipient strain [13]. Transconjugants were select-
ed on Luria-Bertani agar plates supplemented
with sodium azide (100 mg ⁄L) and CTX
(2 mg ⁄L). CTX-, TEM- and SHV-related genes
were amplified from plasmid DNA templates
using specific primers as described previously
[14–17]. DNA sequencing was performed on an
ABI PRISM 373 automated DNA sequencer
(Applied Biosystems, Foster City, CA, USA).
Pulsed-field gel electrophoresis (PFGE) of XbaI-
digested genomic DNA of E. cloacae isolates was
performed using a CHEF MAPPER XA apparatus
(Bio-Rad Laboratories, Hercules, CA, USA)
according to the manufacturer’s recommenda-
tions, with the resulting profiles being interpreted
as described previously [18].
Among 110 E. cloacae isolates, 14 were positive
for the ESBL phenotype by the MIC-based
method (Table 1). Combination-disk synergy
tests using CAZ and CTX ± CLA revealed 17
ESBL-producers. Three isolates (33, 45 and 96)
appeared to be falsely ESBL-negative by the
MIC-based method, following only small MIC
reductions of CAZ and CTX in the presence of
CLA, probably caused by derepression or
hyper-production of AmpC enzymes. All ESBL-
producers were resistant to CAZ. For the 17 ESBL-
producers, the double-disk synergy test using
cefepime and amoxycillin-clavulanic acid showed
the following changes in the cefepime zone
diameter: 5–8 mm increase (n = 5); 3–4 mm in-
crease (n = 10); no change (n = 1); and 1-mm
decrease (n = 1) (Table 1). The remaining 93
isolates showed increases in the cefepime zone
diameter of £ 2 mm.
All 33 ceftazidime-resistant isolates were tested
by IEF and PCR for bla genes. Following DNA
sequencing, the 17 isolates identified as ESBL-
producers were found to harbour SHV-12 (pI 8.2).
One isolate (no. 96) also harboured CTX-M-3 (pI
8.4), and two isolates (33 and 45) also harboured
CTX-M-9 (pI 8.0), generally in accordance with the
combination-disk synergy test. Conjugation
experiments for strains 33 and 45 confirmed the
presence of transferable plasmids (> 50 kb in size),
with a conjugation efficiency of c. 10)4 recombi-
nants per donor cell. The SHV-12 and CTX-M-9
genes were located on the same plasmid, which
was different from the plasmid encoding TEM-1.
A variety of unidentified b-lactamases with pIs of
7.4, 7.6, 7.9, 8.6, 8.8 and 9.0 probably comprised
chromosomally-encoded AmpC enzymes and ⁄ or
their satellite bands on IEF gels.
As in previous reports [4,5], the present study
showed that SHV-12 predominated among ESBL-
producing E. cloacae, with one isolate also
harbouring CTX-M-3 and two isolates also
Table 1. Characteristics of 17 isolates of Enterobacter cloacae producing extended-spectrum b-lactamases
Strain
No.
CTX ⁄CTX + CLA
(MIC mg ⁄L)
CAZ ⁄CAZ + CLA
(MIC mg ⁄L)
FEP zone
diameter in mm
Changes of FEP by zone (mm)
by AMC effect pIs (b-lactamase)
Other pI
values
PFGE
type
15 32 ⁄ 0.5 128 ⁄ 0.25 22 (S) + 6 8.2 (SHV-12) 7.6 A
20 32 ⁄ 0.25 64 ⁄ 0.25 26 (S) + 3 8.2 (SHV-12) 7.6 B
33 256 ⁄ 128 128 ⁄ 32 11 (R) + 8 5.4 (TEM-1) 8.0 (CTX-M-9) 8.2 (SHV-12) 9.0 C
45 256 ⁄ 128 128 ⁄ 32 12 (R) + 6 5.4 (TEM-1) 8.0 (CTX-M-9) 8.2 (SHV-12) 7.6 9.0 C
53 16 ⁄ 0.5 64 ⁄ 0.25 25 (S) + 4 5.4 (TEM-1) 8.2 (SHV-12) 8.6 _a
73 16 ⁄ 0.5 64 ⁄ 0.5 25 (S) + 3 8.2 (SHV-12) 7.6 )
96 128 ⁄ 128 128 ⁄ 32 25 (S) ) 1 5.4 (TEM-1) 8.2 (SHV-12) 8.4 (CTX-M-3) 7.9 D
133 16 ⁄ 1 64 ⁄ 1 24 (S) + 3 8.2 (SHV-12) None E1b
139 16 ⁄ 0.5 64 ⁄ 0.5 23 (S) + 5 5.4 (TEM-1) 8.2 (SHV-12) 8.6 E2b
147 16 ⁄ 1 128 ⁄ 0.5 25 (S) + 3 5.4 (TEM-1) 8.2 (SHV-12) 8.8 F1c
151 16 ⁄ 4 64 ⁄ 8 25 (S) + 0 5.4 (TEM-1) 8.2 (SHV-12) 8.8 G
155 16 ⁄ 0.25 64 ⁄ 0.25 24 (S) + 4 5.4 (TEM-1) 8.2 (SHV-12) 8.8 H
158 16 ⁄ 0.25 128 ⁄ 0.25 24 (S) + 3 5.4 (TEM-1) 8.2 (SHV-12) None F2c
164 16 ⁄ 0.25 64 ⁄ 0.5 22 (S) + 5 5.4 (TEM-1) 8.2 (SHV-12) 8.8 I
169 16 ⁄ 1 128 ⁄ 1 22 (S) + 3 5.4 (TEM-1) 8.2 (SHV-12) 9.0 _
171 16 ⁄ 0.06 32 ⁄ 0.12 24 (S) + 3 5.4 (TEM-1) 8.2 (SHV-12) 7.4 _
172 16 ⁄ 0.25 64 ⁄ 0.5 23 (S) + 4 5.4 (TEM-1) 8.2 (SHV-12) 7.8 _
CTX, cefotaxime; CLA, clavulanic acid; CAZ, ceftazidime; FEP, cefepime; AMC, amoxycillin-clavulanic acid; S, susceptible; R, resistant; PFGE, pulsed-field gel electrophoresis.
aNon-typable.
bStrains 133 and 139 were highly related.
cStrains 147 and 158 were highly related.
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harbouring CTX-M-9. The blaCTX-M-3 gene has
disseminated among Klebsiella isolates from
Taiwan [16], but CTX-M-9 has not been identified
previously in Taiwan, highlighting the continu-
ous emergence and increasing diversity of ESBLs
within E. cloacae in this country. E. cloacae produ-
cing CTX-M-9 are rare, but a few isolates have
been identified in China [19] and Brazil [20].
Previous studies demonstrated that clonal spread
contributed to the increased rates of ESBL-
producing E. cloacae in two other Taiwan hospi-
tals [4,5]. However, excluding five non-typable
isolates, PFGE did not demonstrate a major clonal
relationship among the other 12 typable ESBL-
producers in the present study.
Detection of ESBLs among E. cloacae is made
difficult by the potentially confounding effect
of hyper-produced or derepressed AmpC
enzymes [8]. Although the combination-disk
synergy test seemed to overcome this problem,
the net effects of ESBLs were probably still
higher than those of AmpC for the isolates
investigated in the present study. Although the
use of cefepime as an indicator may improve
the detection of ESBLs [8], variations in the zone
diameters around cefepime disks (from ) 1 to
+8 mm) when combined with an amoxycillin-
clavulanate disk might make the interpretation
of results difficult. Indeed, ESBLs may occasion-
ally have only a minimal effect on the activity
of cefepime (zone diameter ‡ 25 mm), leading to
negligible increases in cefepime zone diameters
(< 5 mm) in the presence of CLA. Furthermore,
although rare, some unusual AmpC enzymes
induced by CLA may have an inhibitory effect
on cefepime, thus reducing cefepime diameters,
as observed with some mutant AmpC producers
of Serratia marcescens [21].
In conclusion, 15% of E. cloacae isolates from
this Taiwan district hospital were identified as
ESBL-producers (predominantly SHV-12, with
some isolates also producing CTX-M-3 and CTX-
M-9). Application of the combination-disk syner-
gy method appears to be simple and reliable, and
may enable routine screening for ESBLs among
E. cloacae in this area, focusing particularly on
CAZ-resistant isolates.
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ABSTRACT
Extended-spectrum b-lactamase (ESBL) produc-
tion was demonstrated in five independent,
multidrug-resistant isolates of enteroaggregative
Escherichia coli (EAEC) from the United Arab
Emirates, representing 11.3% of the EAEC iso-
lates recovered during 1 year. All five isolates
carried the blaCTX-M-15 and the blaTEM-1 genes, the
former positioned 48 bp downstream of an ISecp1
element. In two isolates, the blaCTX-M-15 and
blaTEM-1 genes were located on a 95-kb plasmid.
This is the first detailed description and charac-
terisation of ESBL production in enteroaggrega-
tive E. coli and also the first report of CTX-M-
producing organisms encountered on the Arabian
Peninsula.
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Antibiotic resistance among diarrhoea-causing
bacterial pathogens is a major concern world-
wide, with the production of various extended
spectrum b)lactamases (ESBLs) being a rapidly
emerging problem. In particular, plasmid-encod-
ed cefotaximases (CTX-M enzymes) have shown a
remarkable ability to spread, not only among
nosocomial pathogens, but also among microor-
ganisms causing enteric infections in the commu-
nity [1].
Enteroaggregative Escherichia coli (EAEC) cau-
ses diarrhoea among travellers, but also fre-
quently infects residents of developing and
developed countries [2,3]. EAEC attach to the
intestinal mucosa and induce increased mucus
production and an inflammatory response. EAEC
represent a heterogeneous group of strains that
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